The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Metabotropic Glutamate Receptor 2-Global Market Insights and Sales Trends 2025
Synopsis
The global Metabotropic Glutamate Receptor 2 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metabotropic Glutamate Receptor 2 in various end use industries. The expanding demands from the Anxiety Disorders, Depression, Schizophrenia and Chronic Pain, are propelling Metabotropic Glutamate Receptor 2 market. LY-2607540, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the BMT-133218 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Metabotropic Glutamate Receptor 2 market, driven by demand from China, the second largest economy with some signs of stabilising, the Metabotropic Glutamate Receptor 2 market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metabotropic Glutamate Receptor 2, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metabotropic Glutamate Receptor 2 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metabotropic Glutamate Receptor 2 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metabotropic Glutamate Receptor 2 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metabotropic Glutamate Receptor 2 covered in this report include Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, Johnson & Johnson and Merck & Co Inc, etc.
The global Metabotropic Glutamate Receptor 2 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
Global Metabotropic Glutamate Receptor 2 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metabotropic Glutamate Receptor 2 market, Segment by Type:
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others
Global Metabotropic Glutamate Receptor 2 market, by Application
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Metabotropic Glutamate Receptor 2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Metabotropic Glutamate Receptor 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Metabotropic Glutamate Receptor 2 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metabotropic Glutamate Receptor 2 in various end use industries. The expanding demands from the Anxiety Disorders, Depression, Schizophrenia and Chronic Pain, are propelling Metabotropic Glutamate Receptor 2 market. LY-2607540, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the BMT-133218 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Metabotropic Glutamate Receptor 2 market, driven by demand from China, the second largest economy with some signs of stabilising, the Metabotropic Glutamate Receptor 2 market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metabotropic Glutamate Receptor 2, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metabotropic Glutamate Receptor 2 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metabotropic Glutamate Receptor 2 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metabotropic Glutamate Receptor 2 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metabotropic Glutamate Receptor 2 covered in this report include Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, Johnson & Johnson and Merck & Co Inc, etc.
The global Metabotropic Glutamate Receptor 2 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
Global Metabotropic Glutamate Receptor 2 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metabotropic Glutamate Receptor 2 market, Segment by Type:
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others
Global Metabotropic Glutamate Receptor 2 market, by Application
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Metabotropic Glutamate Receptor 2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Metabotropic Glutamate Receptor 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Metabotropic Glutamate Receptor 2 Market Overview
1.1 Metabotropic Glutamate Receptor 2 Product Overview
1.2 Metabotropic Glutamate Receptor 2 Market Segment by Type
1.2.1 LY-2607540
1.2.2 BMT-133218
1.2.3 DT-2442
1.2.4 JNJ-40411813
1.2.5 Others
1.3 Global Metabotropic Glutamate Receptor 2 Market Size by Type
1.3.1 Global Metabotropic Glutamate Receptor 2 Market Size Overview by Type (2018-2029)
1.3.2 Global Metabotropic Glutamate Receptor 2 Historic Market Size Review by Type (2018-2023)
1.3.3 Global Metabotropic Glutamate Receptor 2 Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Metabotropic Glutamate Receptor 2 Sales Breakdown by Type (2018-2023)
1.4.2 Europe Metabotropic Glutamate Receptor 2 Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Metabotropic Glutamate Receptor 2 Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Breakdown by Type (2018-2023)
2 Global Metabotropic Glutamate Receptor 2 Market Competition by Company
2.1 Global Top Players by Metabotropic Glutamate Receptor 2 Sales (2018-2023)
2.2 Global Top Players by Metabotropic Glutamate Receptor 2 Revenue (2018-2023)
2.3 Global Top Players by Metabotropic Glutamate Receptor 2 Price (2018-2023)
2.4 Global Top Manufacturers Metabotropic Glutamate Receptor 2 Manufacturing Base Distribution, Sales Area, Product Type
2.5 Metabotropic Glutamate Receptor 2 Market Competitive Situation and Trends
2.5.1 Metabotropic Glutamate Receptor 2 Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Metabotropic Glutamate Receptor 2 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 2 as of 2022)
2.7 Date of Key Manufacturers Enter into Metabotropic Glutamate Receptor 2 Market
2.8 Key Manufacturers Metabotropic Glutamate Receptor 2 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Metabotropic Glutamate Receptor 2 Status and Outlook by Region
3.1 Global Metabotropic Glutamate Receptor 2 Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Metabotropic Glutamate Receptor 2 Historic Market Size by Region
3.2.1 Global Metabotropic Glutamate Receptor 2 Sales in Volume by Region (2018-2023)
3.2.2 Global Metabotropic Glutamate Receptor 2 Sales in Value by Region (2018-2023)
3.2.3 Global Metabotropic Glutamate Receptor 2 Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Metabotropic Glutamate Receptor 2 Forecasted Market Size by Region
3.3.1 Global Metabotropic Glutamate Receptor 2 Sales in Volume by Region (2024-2029)
3.3.2 Global Metabotropic Glutamate Receptor 2 Sales in Value by Region (2024-2029)
3.3.3 Global Metabotropic Glutamate Receptor 2 Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Metabotropic Glutamate Receptor 2 by Application
4.1 Metabotropic Glutamate Receptor 2 Market Segment by Application
4.1.1 Anxiety Disorders
4.1.2 Depression
4.1.3 Schizophrenia
4.1.4 Chronic Pain
4.1.5 Others
4.2 Global Metabotropic Glutamate Receptor 2 Market Size by Application
4.2.1 Global Metabotropic Glutamate Receptor 2 Market Size Overview by Application (2018-2029)
4.2.2 Global Metabotropic Glutamate Receptor 2 Historic Market Size Review by Application (2018-2023)
4.2.3 Global Metabotropic Glutamate Receptor 2 Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Metabotropic Glutamate Receptor 2 Sales Breakdown by Application (2018-2023)
4.3.2 Europe Metabotropic Glutamate Receptor 2 Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Metabotropic Glutamate Receptor 2 Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Breakdown by Application (2018-2023)
5 North America Metabotropic Glutamate Receptor 2 by Country
5.1 North America Metabotropic Glutamate Receptor 2 Historic Market Size by Country
5.1.1 North America Metabotropic Glutamate Receptor 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2018-2023)
5.1.3 North America Metabotropic Glutamate Receptor 2 Sales in Value by Country (2018-2023)
5.2 North America Metabotropic Glutamate Receptor 2 Forecasted Market Size by Country
5.2.1 North America Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2024-2029)
5.2.2 North America Metabotropic Glutamate Receptor 2 Sales in Value by Country (2024-2029)
6 Europe Metabotropic Glutamate Receptor 2 by Country
6.1 Europe Metabotropic Glutamate Receptor 2 Historic Market Size by Country
6.1.1 Europe Metabotropic Glutamate Receptor 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2018-2023)
6.1.3 Europe Metabotropic Glutamate Receptor 2 Sales in Value by Country (2018-2023)
6.2 Europe Metabotropic Glutamate Receptor 2 Forecasted Market Size by Country
6.2.1 Europe Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2024-2029)
6.2.2 Europe Metabotropic Glutamate Receptor 2 Sales in Value by Country (2024-2029)
7 Asia-Pacific Metabotropic Glutamate Receptor 2 by Region
7.1 Asia-Pacific Metabotropic Glutamate Receptor 2 Historic Market Size by Region
7.1.1 Asia-Pacific Metabotropic Glutamate Receptor 2 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Metabotropic Glutamate Receptor 2 Forecasted Market Size by Region
7.2.1 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Metabotropic Glutamate Receptor 2 Sales in Value by Region (2024-2029)
8 Latin America Metabotropic Glutamate Receptor 2 by Country
8.1 Latin America Metabotropic Glutamate Receptor 2 Historic Market Size by Country
8.1.1 Latin America Metabotropic Glutamate Receptor 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2018-2023)
8.1.3 Latin America Metabotropic Glutamate Receptor 2 Sales in Value by Country (2018-2023)
8.2 Latin America Metabotropic Glutamate Receptor 2 Forecasted Market Size by Country
8.2.1 Latin America Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2024-2029)
8.2.2 Latin America Metabotropic Glutamate Receptor 2 Sales in Value by Country (2024-2029)
9 Middle East and Africa Metabotropic Glutamate Receptor 2 by Country
9.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Historic Market Size by Country
9.1.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Forecasted Market Size by Country
9.2.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Addex Therapeutics Ltd
10.1.1 Addex Therapeutics Ltd Company Information
10.1.2 Addex Therapeutics Ltd Introduction and Business Overview
10.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Products Offered
10.1.5 Addex Therapeutics Ltd Recent Development
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company Company Information
10.2.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Products Offered
10.2.5 Bristol-Myers Squibb Company Recent Development
10.3 Denovo Biopharma LLC
10.3.1 Denovo Biopharma LLC Company Information
10.3.2 Denovo Biopharma LLC Introduction and Business Overview
10.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Products Offered
10.3.5 Denovo Biopharma LLC Recent Development
10.4 Domain Therapeutics SA
10.4.1 Domain Therapeutics SA Company Information
10.4.2 Domain Therapeutics SA Introduction and Business Overview
10.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Products Offered
10.4.5 Domain Therapeutics SA Recent Development
10.5 Eli Lilly and Company
10.5.1 Eli Lilly and Company Company Information
10.5.2 Eli Lilly and Company Introduction and Business Overview
10.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Products Offered
10.5.5 Eli Lilly and Company Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Merck & Co Inc
10.7.1 Merck & Co Inc Company Information
10.7.2 Merck & Co Inc Introduction and Business Overview
10.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Products Offered
10.7.5 Merck & Co Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Metabotropic Glutamate Receptor 2 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Metabotropic Glutamate Receptor 2 Industrial Chain Analysis
11.4 Metabotropic Glutamate Receptor 2 Market Dynamics
11.4.1 Metabotropic Glutamate Receptor 2 Industry Trends
11.4.2 Metabotropic Glutamate Receptor 2 Market Drivers
11.4.3 Metabotropic Glutamate Receptor 2 Market Challenges
11.4.4 Metabotropic Glutamate Receptor 2 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Metabotropic Glutamate Receptor 2 Distributors
12.3 Metabotropic Glutamate Receptor 2 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
